Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Trifluoperazine dihydrochloride
Cat. No.:
OB0225LY-0425
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Product Overview
Description:
Trifluoperazine dihydrochloride is a classic antipsychotic drug with a wide range of biological activities that affect a variety of neurotransmission systems.
Synonym:
Trifluoperazine 2HCl; SKF5019; Urinox; 440-17-5; Trifluperazine; Trifluoroperazine; Trifluoperazin; 10-[3-(4-Methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine; Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine
CAS No.:
440-17-5
Compound CID:
5566
Formula:
C21H26Cl2F3N3S
Formula Weight:
480.43
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Trifluoperazine dihydrochloride can be used in neuroscience research to help understand neurotransmitter imbalances and their role in mental illness.
Library Information
Targets:
G protein-coupled receptors (GPCRs); ABC transporters; Calcium-binding proteins/kinases
Receptors:
Adrenergic receptor; CaMK; Dopamine receptor; P-gp (P-glycoprotein)
Pathways:
Membrane transporter/Ion channel; Autophagy; GPCR/G protein; Microbiology/Virology; Neuronal signaling
Plate Number:
AOCL-6
Plate Location:
d11
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
82 mg/mL; 170.7 mM
Water Max Solubility:
88 mg/mL; 183.2 mM
Ethanol Max Solubility:
89 mg/mL; 185.3 mM
